Literature DB >> 35306603

Prediction, assessment, and management of suboptimal GnRH agonist trigger: a systematic review.

Hadas Ganer Herman1, Eran Horowitz2, Yossi Mizrachi2, Jacob Farhi2, Arieh Raziel2, Ariel Weissman2.   

Abstract

PURPOSE: This systematic review aimed to identify baseline patient demographic and controlled ovarian stimulation characteristics associated with a suboptimal response to GnRHa triggering, and available options for prevention and management of suboptimal response.
METHODS: PubMed, Google Scholar, Medline, and the Cochrane Library were searched for keywords related to GnRHa triggering, and peer-reviewed articles from January 2000 to September 2021 included.
RESULTS: Thirty-seven studies were included in the review. A suboptimal response to GnRHa triggering was more likely following long-term or recent oral contraceptive use and with a low or high body mass index. Low basal serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol serum levels were correlated with suboptimal oocyte yield, as was a low serum LH level on the day of triggering. A prolonged stimulation period and increased gonadotropin requirements were correlated with suboptimal response to triggering. Post-trigger LH < 15 IU/L best correlated with an increased risk for empty follicle syndrome and a lower oocyte retrieval rate. Retriggering with hCG may be considered in patients with suboptimal response according to post-trigger LH, as in cases of failed aspiration.
CONCLUSION: Pre-treatment assessment of patient characteristics, with pre- and post-triggering assessment of clinical and endocrine cycle characteristics, may identify cases at risk for suboptimal response to GnRHa triggering and optimize its utilization.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  GnRH agonist (GnRHa); In vitro fertilization (IVF); Luteinizing hormone (LH); Ovulation triggering; Review

Mesh:

Substances:

Year:  2022        PMID: 35306603      PMCID: PMC8956771          DOI: 10.1007/s10815-021-02359-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  51 in total

1.  Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.

Authors:  Y Gonen; H Balakier; W Powell; R F Casper
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

2.  Dynamic testing in reproductive endocrinology.

Authors:  W D Schlaff
Journal:  Fertil Steril       Date:  1986-05       Impact factor: 7.329

Review 3.  Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.

Authors:  Mohamed A F M Youssef; Fulco Van der Veen; Hesham G Al-Inany; Monique H Mochtar; Georg Griesinger; Mohamed Nagi Mohesen; Ismail Aboulfoutouh; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2014-10-31

4.  Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.

Authors:  Daniel Griffin; Claudio Benadiva; Nicole Kummer; Tara Budinetz; John Nulsen; Lawrence Engmann
Journal:  Fertil Steril       Date:  2012-04-03       Impact factor: 7.329

5.  Rescue hCG to treat empty follicle syndrome after the use of a GnRH agonist as oocyte maturation trigger: First report on fresh embryo transfer and clinical pregnancy.

Authors:  Georgios Christopoulos; Antonios Vlismas; Emil Barsoum-Derias; Salem El-Shawarby; Geoffrey Trew; Stuart Lavery
Journal:  Hum Fertil (Camb)       Date:  2015-09-23       Impact factor: 2.767

6.  Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist.

Authors:  J Itskovitz; R Boldes; J Levron; Y Erlik; L Kahana; J M Brandes
Journal:  Fertil Steril       Date:  1991-08       Impact factor: 7.329

7.  Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study.

Authors:  George T Lainas; Tryfon G Lainas; Ioannis A Sfontouris; Christos A Venetis; Julia K Bosdou; Aikaterini Chatzimeletiou; Grigorios F Grimbizis; Basil C Tarlatzis; Efstratios M Kolibianakis
Journal:  Reprod Biomed Online       Date:  2019-10-15       Impact factor: 3.828

8.  Ideal lag time from ovulation to oocyte aspiration using a GnRH agonist trigger.

Authors:  Eliyakim Hershkop; Allen Khakshooy; Joshua Simons; Amir Weiss; Joel Geslevich; Shlomit Goldman; Shira Baram; Simon Nothman; Ronit Beck-Fruchter
Journal:  J Gynecol Obstet Hum Reprod       Date:  2021-01-02

Review 9.  GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis.

Authors:  M A F Youssef; Hatem I Abdelmoty; Mohamed A S Ahmed; Maged Elmohamady
Journal:  J Adv Res       Date:  2015-01-21       Impact factor: 10.479

10.  Empty Follicle Syndrome Following GnRHa Trigger in PCOS Patients Undergoing IVF Cycles.

Authors:  Krishna Deepika; Davuluri Sindhuma; Bijlani Kiran; Nair Ravishankar; Praneesh Gautham; Rao Kamini
Journal:  J Reprod Infertil       Date:  2018 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.